UBS AM’s Nuvectis Pharma NVCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.94K Buy
+92
New +$1.94K ﹤0.01% 4049

Other funds holding NVCT

UBS AM's NVCT Position: Q3 2026 in Review

UBS AM opened a new position in Nuvectis Pharma (NVCT) in Q3 2026: 92 shares worth $1.94K. The stake represents ﹤0.01% of the portfolio and ranks #4049 among its holdings.

76 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.

  • UBS AM held 92 shares of Nuvectis Pharma worth $1.94K as of Q3 2026.
  • Nuvectis Pharma was a new UBS AM position in Q3 2026.
  • Nuvectis Pharma made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4049 holding.
  • 76 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.